Silicones may lead to cell death

 

Nijmegen, Netherlands (June 12, 2020) — Silicone molecules from breast implants can initiate processes in human cells that lead to cell death. Researchers from Radboud University have demonstrated this in a new study that will be published on 12 June in Scientific Reports. „However, there are still many questions about what this could mean for the health effects of silicone breast implants. More research is therefore urgently needed,“ says Ger Pruijn, professor of Biomolecular Chemistry at Radboud University.

The possible side effects of silicone breast implants have been debated for decades. There are known cases where the implants have led to severe fatigue, fever, muscle and joint aches, and concentration disturbance. However, there is as yet no scientific study demonstrating the effect silicone molecules can have on human cells that could explain these side effects.

 

Silicone in the body

It is a known fact that breast implants ‚bleed‘, i.e. silicone molecules from the implant pass through the shell and enter the body. Earlier research, in 2016, by Dr Rita Kappel, plastic surgeon, and Radboud university medical center, found that silicone molecules can then migrate through the body via the bloodstream or lymphatic system. The biochemists at Radboud University next asked themselves the follow-up question: what effect might silicone molecules have on cells exposed to it?

 

Cultured cells

Experiments with cultured cells showed that silicones appeared to initiate molecular processes that lead to cell death. „We observed similarities with molecular processes related to programmed cell death, a natural process called apoptosis that has an important function in clearing cells in our body. This effect appeared to depend on the dose of silicone and the size of the silicone molecules. The smaller the molecule, the stronger the effect,“ according to Pruijn.

To investigate the effect of silicones on human cells, the researchers have added small silicone molecules – which also occur in silicone breast implants – to three different types of cultured human cells. „One cell was more sensitive to the effect of silicones than the other two cell types. This suggests that the sensitivity of human cells to silicones varies.“

 

Open questions

The effects the researchers have found lead to many new questions. „We observed that silicones induce molecular changes in cells, but we don’t know yet whether these changes could, for example, lead to an autoimmune response, which could in part explain the negative side effects of implants,“ says Pruijn.

„Caution is advised with drawing conclusions based on these findings because we used cultured cells in our research, not specific human cells such as brain cells or muscle cells. Further research is required to get more clarity.“

 

 

Image: Silicone molecules from breast implants can initiate processes in human cells that lead to cell death. Researchers from Radboud University have demonstrated this in a new study that will be published on 12 June in Scientific Reports. ‚However, there are still many questions about what this could mean for the health effects of silicone breast implants. More research is therefore urgently needed,‘ says Ger Pruijn, professor of Biomolecular Chemistry at Radboud University. Credit: Radboud University

 


Radboud University Nijmegen, 12.06.2020 (tB).

Schlagwörter:

MEDICAL NEWS

IU School of Medicine researchers develop blood test for anxiety
COVID-19 pandemic increased rates and severity of depression, whether people…
COVID-19: Bacterial co-infection is a major risk factor for death,…
Regenstrief-led study shows enhanced spiritual care improves well-being of ICU…
Hidden bacteria presents a substantial risk of antimicrobial resistance in…

SCHMERZ PAINCARE

Hydromorphon Aristo® long ist das führende Präferenzpräparat bei Tumorschmerz
Sorgen und Versorgen – Schmerzmedizin konkret: „Sorge als identitätsstiftendes Element…
Problem Schmerzmittelkonsum
Post-Covid und Muskelschmerz
Kopfschmerz bei Übergebrauch von Schmerz- oder Migränemitteln

DIABETES

Wie das Dexom G7 abstrakte Zahlen mit Farben greifbar macht…
Diabetes mellitus: eine der großen Volkskrankheiten im Blickpunkt der Schmerzmedizin
Suliqua®: Einfacher hin zu einer guten glykämischen Kontrolle
Menschen mit Diabetes während der Corona-Pandemie unterversorgt? Studie zeigt auffällige…
Suliqua® zur Therapieoptimierung bei unzureichender BOT

ERNÄHRUNG

Positiver Effekt der grünen Mittelmeerdiät auf die Aorta
Natriumaufnahme und Herz-Kreislaufrisiko
Tierwohl-Fleisch aus Deutschland nur mäßig attraktiv in anderen Ländern
Diät: Gehirn verstärkt Signal an Hungersynapsen
Süßigkeiten verändern unser Gehirn

ONKOLOGIE

Strahlentherapie ist oft ebenso effizient wie die OP: Neues vom…
Zanubrutinib bei chronischer lymphatischer Leukämie: Zusatznutzen für bestimmte Betroffene
Eileiter-Entfernung als Vorbeugung gegen Eierstockkrebs akzeptiert
Antibiotika als Störfaktor bei CAR-T-Zell-Therapie
Bauchspeicheldrüsenkrebs: Spezielle Diät kann Erfolg der Chemotherapie beeinflussen

MULTIPLE SKLEROSE

Multiple Sklerose: Aktuelle Immunmodulatoren im Vergleich
Neuer Biomarker für Verlauf von Multipler Sklerose
Multiple Sklerose: Analysen aus Münster erhärten Verdacht gegen das Epstein-Barr-Virus
Aktuelle Daten zu Novartis Ofatumumab und Siponimod bestätigen Vorteil des…
Multiple Sklerose durch das Epstein-Barr-Virus – kommt die MS-Impfung?

PARKINSON

Meilenstein in der Parkinson-Forschung: Neuer Alpha-Synuclein-Test entdeckt die Nervenerkrankung vor…
Neue Erkenntnisse für die Parkinson-Therapie
Cochrane Review: Bewegung hilft, die Schwere von Bewegungssymptomen bei Parkinson…
Technische Innovationen für eine maßgeschneiderte Parkinson-Diagnostik und Therapie
Biomarker und Gene: neue Chancen und Herausforderungen für die Parkinson-Diagnose…